GlaxoSmithkline Consumer Healthcare Ltd, one of the leading players in the health food drinks market in India, has temporarily suspended operations at its Nabha plant in Punjab following a flash strike by the workers.
“Due to certain disruption created by the workforce/flash strike by the workforce, the management of the company has decided to suspend operations temporarily at its factory located at Nabha with effect from the night of May 21, 2016 in the interest of safety and security of its employees and to protect the assets of the factory,” said GlaxoSmithkline Consumer Healthcare Ltd in a BSE filing today.
Nabha is one of the three company owned manufacturing sites of GSKCH in India. The other two are located at Rajamundry (Andhra Pradesh) and Sonepat (Haryana). Along with its flagship product Horlicks, the company also manufactures Boost, Viva, Maltova, etc. In addition, it promotes and distributes a number of products in diverse categories including prominent brands such as Eno, Crocin, Iodex, etc.
“Due to certain disruption created by the workforce/flash strike by the workforce, the management of the company has decided to suspend operations temporarily at its factory located at Nabha with effect from the night of May 21, 2016 in the interest of safety and security of its employees and to protect the assets of the factory,” said GlaxoSmithkline Consumer Healthcare Ltd in a BSE filing today.
Nabha is one of the three company owned manufacturing sites of GSKCH in India. The other two are located at Rajamundry (Andhra Pradesh) and Sonepat (Haryana). Along with its flagship product Horlicks, the company also manufactures Boost, Viva, Maltova, etc. In addition, it promotes and distributes a number of products in diverse categories including prominent brands such as Eno, Crocin, Iodex, etc.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%